Interim report for the second quarter of 2009
Geschreven op 29.07.2009
Bayer robust in a difficult environment
- HealthCare strong – further growth at CropScience – MaterialScience stabilized
- Group sales EUR 8,009 million (minus 5.9 percent)
- EBITDA before special items EUR 1,765 million (minus 6.9 percent)
- EBIT before special items EUR 1,101 million (minus 11.8 percent)
- Group net income EUR 532 million (minus 7.3 percent)
- Net cash flow EUR 1,399 million (plus 57.4 percent)
- Earnings targets for full year 2009 confirmed
Lees meer / Read more
« Terug naar overzicht
